Acasti Pharma Inc. (ACST) SEC News Jan. 28, 2026, 16:24 UTC 0 0 comments New Form SCHEDULE 13G/A - Grace Therapeutics, Inc. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001493152-26-003982 <b>Size:</b> 9 KB Comment Full text
Elutia Inc (ELUT) SEC News Jan. 28, 2026, 16:17 UTC 0 0 comments New Form SCHEDULE 13G/A - ELUTIA INC. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001493152-26-003980 <b>Size:</b> 9 KB Comment Full text
Coya Therapeutics Inc (COYA) SEC News Jan. 28, 2026, 16:14 UTC 0 0 comments New Form SCHEDULE 13G/A - Coya Therapeutics, Inc. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001493152-26-003978 <b>Size:</b> 9 KB Comment Full text
Biofrontera Inc. (BFRI) SEC News Jan. 28, 2026, 16:10 UTC 0 0 comments New Form SCHEDULE 13G/A - Biofrontera Inc. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001493152-26-003976 <b>Size:</b> 9 KB Comment Full text
VolitionRX Limited (VNRX) SEC News Jan. 28, 2026, 16:10 UTC 0 0 comments New Form D/A - VOLITIONRX LTD <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001477932-26-000461 <b>Size:</b> 18 KB Comment Full text
Aprea Therapeutics Inc. (APRE) SEC News Jan. 28, 2026, 16:02 UTC 0 0 comments New Form SCHEDULE 13G/A - Aprea Therapeutics, Inc. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001493152-26-003971 <b>Size:</b> 9 KB Comment Full text
Repare Therapeutics Inc (RPTX) SEC News Jan. 28, 2026, 14:48 UTC 1 0 comments New Form 25-NSE - Repare Therapeutics Inc. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001354457-26-000100 <b>Size:</b> 3 KB Comment Full text
Quoin Pharmaceuticals Ltd DRC (QNRX) SEC News Jan. 28, 2026, 13:06 UTC 0 0 comments New Form SCHEDULE 13G - Quoin Pharmaceuticals, Ltd. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001716774-26-000006 <b>Size:</b> 8 KB Comment Full text
Akanda Corp (AKAN) SEC News Jan. 28, 2026, 12:54 UTC 0 0 comments New Form F-1/A - AKANDA CORP. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001213900-26-008630 <b>Size:</b> 200 KB Comment Full text
MEDTECS INTERNATIONAL CORP LTD (546) SEC News Jan. 28, 2026, 12:46 UTC 0 0 comments General Announcement: Changes to the Composition of the Board of Directors and Board Committees Comment Full text